GLP-1 Zepbound Is Approved As First Drug For Sleep Apnea
MONDAY, Dec. 23, 2024 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound. In a news release published Dec. 20, the FDA stated that Zepbound, part of the GLP-1 receptor agonist medicinesContinue Reading